Lifevantage Corp income statement
In fiscal 2026, Lifevantage Corp reported revenue of $183m, down 20.1% on the year before, operating income of $6.1m (a 3.3% margin) and net income of $5.1m, or $0.40 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2011Jun 2011 | 2012Jun 2012 | 2013Jun 2013 | 2014Jun 2014 | 2015Jun 2015 | 2016Jun 2016 | 2017Jun 2017 | 2018Jun 2018 | 2019Jun 2019 | 2020Jun 2020 | 2021Jun 2021 | 2022Jun 2022 | 2023Jun 2023 | 2024Jun 2024 | 2025Jun 2025 | 2026Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 39 | 126 | 208 | 214 | 190 | 207 | 199 | 203 | 226 | 233 | 220 | 206 | 213 | 200 | 229 | 183 |
| Cost of revenue | 6 | 18 | 32 | 33 | 28 | 34 | 33 | 35 | 38 | 38 | 38 | 38 | 43 | 41 | 45 | 41 |
| Gross profit | 33 | 108 | 172 | 181 | 162 | 173 | 166 | 168 | 188 | 195 | 182 | 168 | 170 | 159 | 184 | 142 |
| Research and development | 1 | 1 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Selling, general and administrative | — | 29 | 58 | 57 | 57 | 56 | 65 | 60 | 70 | 68 | 61 | 63 | 71 | 68 | 69 | 58 |
| Selling and marketing | 21 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| General and administrative | 8 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | 4 | 21 | 12 | 19 | 14 | 13 | 4 | 10 | 10 | 15 | 18 | 8 | 4 | 4 | 12 | 6 |
| Interest expense | 6 | 0 | 0 | 3 | 3 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | −0 | −0 | — | — |
| Income before tax | −51 | 15 | 11 | 17 | 11 | 9 | 3 | 10 | 9 | 15 | 17 | 5 | 4 | 4 | 12 | 6 |
| Income tax | 0 | 2 | 4 | 5 | 4 | 3 | 1 | 4 | 2 | 3 | 4 | 2 | 1 | 1 | 2 | 1 |
| Net income | −51 | 12 | 8 | 11 | 7 | 6 | 2 | 6 | 7 | 12 | 13 | 3 | 3 | 3 | 10 | 5 |
| Diluted EPS | −$4.83 | $0.77 | $0.42 | $0.71 | $0.50 | $0.42 | $0.11 | $0.41 | $0.50 | $0.79 | $0.90 | $0.24 | $0.20 | $0.23 | $0.75 | $0.40 |
| Diluted shares (average) | 10m | 17m | 18m | 16m | 14m | 15m | 14m | 14m | 15m | 15m | 14m | 13m | 13m | 13m | 13m | 13m |
| EBITDA | 4 | 22 | 14 | 22 | 16 | 15 | 6 | 12 | 12 | 18 | 21 | 11 | 8 | 8 | 15 | 9 |
| Quarter | 2025 Q1Sept 2024 | 2025 Q2Dec 2024 | 2025 Q3Mar 2025 | 2025 Q4Jun 2025 | 2026 Q1Sept 2025 | 2026 Q2Dec 2025 | 2026 Q3Mar 2026 | 2026 Q4Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 47 | 68 | 58 | 55 | 48 | 49 | 44 | 42 |
| Cost of revenue | 9 | 13 | 11 | 11 | 10 | 13 | 9 | 9 |
| Gross profit | 38 | 55 | 47 | 44 | 38 | 36 | 35 | 33 |
| Research and development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, general and administrative | 15 | 19 | 17 | 19 | 15 | 16 | 14 | 14 |
| Operating income | 3 | 3 | 4 | 2 | 2 | 0 | 2 | 2 |
| Income before tax | 3 | 3 | 4 | 2 | 2 | 0 | 2 | 2 |
| Income tax | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Net income | 2 | 3 | 3 | 2 | 2 | 0 | 1 | 1 |
| Diluted EPS | $0.14 | $0.19 | $0.26 | $0.15 | $0.17 | $0.02 | $0.11 | $0.10 |
| EBITDA | 3 | 4 | 5 | 3 | 3 | 1 | 2 | 2 |
Compare with peers
- Mannatech Inc income statement
- Honest Company, Inc. income statement
- Natures Sunshine Products Inc income statement
- Oddity Tech Ltd income statement
- Usana Health Sciences Inc income statement
Head to head: LFVN vs MTEXHNST vs LFVNLFVN vs NATR
More: Personal Care Products stocks compared, Consumer Staples sector, rankings of US companies